The expression of miR-133a-3p and CTGF in H9C2 cells. حسب Niu Liu (2104450)

الموضوعات:

Table 2_Bibliometric analysis of global research on the clinical applications of aminoglycoside antibiotics: improving efficacy and decreasing risk.docx حسب Tengxiang Zhao (20749475)

"…Therapeutic drug monitoring should be performed in vulnerable populations, such as the elderly, children, and infants, to improve efficacy and reduce toxicity. Avoiding prolonged dosing cycles and refraining from using AGs in patients with the m.1555 A > G gene variant can significantly mitigate the risk of ototoxicity. …"

Table 1_Bibliometric analysis of global research on the clinical applications of aminoglycoside antibiotics: improving efficacy and decreasing risk.docx حسب Tengxiang Zhao (20749475)

"…Therapeutic drug monitoring should be performed in vulnerable populations, such as the elderly, children, and infants, to improve efficacy and reduce toxicity. Avoiding prolonged dosing cycles and refraining from using AGs in patients with the m.1555 A > G gene variant can significantly mitigate the risk of ototoxicity. …"

The expression of CTGF in miR-133a-3p inhibitor and mimics transfected H9C2 cells. حسب Niu Liu (2104450)

الموضوعات:

La,Al-Codoped SrTiO₃ as a Photocatalyst in Overall Water Splitting: Significant Surface Engineering Effects on Defect Engineering حسب Yalei Qin (11360407)

A Novel Phospholipase A₁ Gene from Tritipyrum Improves Wheat Early Ripening and Salt Tolerance حسب Jv Zhang (11175243)

"…However, the malondialdehyde content decreased. Conversely, <i>TtPLA</i>_<i>1–1</i> downregulation in “Y1805” using a virus-induced gene silencing system decreased the salt tolerance. …"

A Novel Phospholipase A₁ Gene from Tritipyrum Improves Wheat Early Ripening and Salt Tolerance حسب Jv Zhang (11175243)

"…However, the malondialdehyde content decreased. Conversely, <i>TtPLA</i>_<i>1–1</i> downregulation in “Y1805” using a virus-induced gene silencing system decreased the salt tolerance. …"

Data Sheet 2_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf حسب Mi-Ae Lyu (20413646)

"…UCB-Treg and ruxolitinib combination also downregulates the soluble form of inflammatory cytokines including IFN-γ, IP-10, TNF-α, IL-6, sCD40L, IL-17A, IL-17F, IL-1α, and LIF in cocultures. The addition of ruxolitinib increases UCB-Treg cell persistence in peripheral blood in vivo and decreases the soluble form of human inflammatory cytokines including IFN-γ, TNF-α, and sCD40L in plasma along with improvement of skin lesions in SLE xenografts. …"

Data Sheet 3_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf حسب Mi-Ae Lyu (20413646)

"…UCB-Treg and ruxolitinib combination also downregulates the soluble form of inflammatory cytokines including IFN-γ, IP-10, TNF-α, IL-6, sCD40L, IL-17A, IL-17F, IL-1α, and LIF in cocultures. The addition of ruxolitinib increases UCB-Treg cell persistence in peripheral blood in vivo and decreases the soluble form of human inflammatory cytokines including IFN-γ, TNF-α, and sCD40L in plasma along with improvement of skin lesions in SLE xenografts. …"

Data Sheet 1_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf حسب Mi-Ae Lyu (20413646)

"…UCB-Treg and ruxolitinib combination also downregulates the soluble form of inflammatory cytokines including IFN-γ, IP-10, TNF-α, IL-6, sCD40L, IL-17A, IL-17F, IL-1α, and LIF in cocultures. The addition of ruxolitinib increases UCB-Treg cell persistence in peripheral blood in vivo and decreases the soluble form of human inflammatory cytokines including IFN-γ, TNF-α, and sCD40L in plasma along with improvement of skin lesions in SLE xenografts. …"

Select metabolites that are significantly altered in the <i>cop</i>^- strain when cultured in presence of 5 μM Cu(II)^b'*'. حسب Javiera Norambuena (137228)

DataSheet1_PagSOD2a improves poplar salt tolerance by elevating superoxide dismutase activity and decreasing malondialdehyde contents.zip حسب Lieding Zhou (16427928)

Pretreatment of BM-MSCs improves the survival rate and incidence of DCS. حسب Chen Lu (135200)

Effect of BM-MSCs in improving DCS induced lung injury. حسب Chen Lu (135200)

<i>ogt-1; eel-1 +</i> Pan-neuronal OGT-1 have decreased sensitivity to electroshock and improved locomotion. حسب Nirthieca Suthakaran (11731101)

"…<p>Shown are each genotype ran through the electroconvulsive seizure assay for 3 seconds at 47V in saline control group. (A) Average time of recovery was significantly decreased in <i>ogt-1; eel-1</i> + Pan-neuronal OGT-1 worms, <i>Ogt-1(ok430) III; eel-1(bgg1) IV; bggSi2[Prab-3</i>::<i>ogt-1a] II</i> (n = 33), in comparison to <i>ogt-1;eel-1</i> double mutants (n = 30) but not significantly different from <i>eel-1</i> null mutants (n = 26). …"

Treatment with ICs causes a significant decrease in podocyte proliferation. حسب George Haddad (470789)

Table_1_Improvement of Emotional Empathy and Cluster B Personality Disorder Symptoms Associated With Decreased Cocaine Use Severity.docx حسب Matthias Vonmoos (759842)

"…In contrast to a significant reduction of prosocial behavior at baseline in the combined cocaine user group, specifically decreasers were not statistically distinguishable from controls at the follow-up.…"

Wear morphology: (a) UT, (b) SP1, (c) SP2, and (d) SP3. حسب Huashen Guan (20454677)

الموضوعات:

Residual stress of various samples: (a) surface residual stress and (b) residual stress in the depth direction. حسب Huashen Guan (20454677)

الموضوعات:

a-d. Difference in (a) probing depth; (b) clinical attachment level; (c) bleeding on probing, and (d) plaque index values between baseline and six months after treatment using syst... حسب Iva Milinkovic (22331710)

الموضوعات: